Synthekine.com

Ping response time 3ms Excellent ping
Domain provide by godaddy.com. Domain ID : 2300170378_DOMAIN_COM-VRSN
Created : 2018-08-21T00:34:12Z. Expired: 2026-08-21T00:34:12Z (0 Years, 206 Days left)
Host name 162.159.134.42, IP address: 162.159.134.42

System updated on 2026/01/26

Keyword Suggestion

Synthekine therapeutics

Synthekine inc

Synthekine logo

Synthekine stock

Synthekine stk-012

Synthekine linkedin

Synthekine hq

Synthekine news

Synthekine merck

Synthekine layoffs

Synthekine location

Synthekine pipeline

Synthekine and sanofi

Synthekine headquarters

Synthekine.com lookup results from whois.godaddy.com server:

Network

Owner

Abuse

Technical support

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 162.159.134.42

Fetching Web Sites Hosted

Site Inspections

Google
https://www.bing.com/ck/a?!&&p=a7bc3700fa3046b78e421908a1597610a8f2398da91f8019698e269ca820094cJmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&ntb=1
Sign in - Google Accounts
https://www.bing.com/ck/a?!&&p=bbee7d5bbe2a28e6bc33925500d9dc901380c82a75c53e39f1072c484b3e3d72JmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly9hY2NvdW50cy5nb29nbGUuY29tLw&ntb=1
Google Drive: Sign-in
https://www.bing.com/ck/a?!&&p=1645444ae38181cabdabb7dbc62d14e660fd399a274158872e4cf6d4d4e7bdc7JmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly9kcml2ZS5nb29nbGUuY29tLw&ntb=1
Google Search
https://www.bing.com/ck/a?!&&p=7b556ffcd9328d1c118628b8c1b7fbd98c6c9ae01fdf2e4508daf143c7d32e66JmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly9vZ3MuZ29vZ2xlLmNvbS93aWRnZXQvZW1wdHk&ntb=1
Google Translate
https://www.bing.com/ck/a?!&&p=5ee4a51d9428b08727c44cd407436f2b8c370038488e9da7dbc9131f327e67daJmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly90cmFuc2xhdGUuZ29vZ2xlLmNvbS8&ntb=1
Sign in - Google Accounts
https://www.bing.com/ck/a?!&&p=5fd4f51cf1071f05a65a7fd6797cba48efc64e8b1f07ce5ed37dc808359d73c3JmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly9jbGFzc3Jvb20uZ29vZ2xlLmNvbS8&ntb=1
Google Maps
https://www.bing.com/ck/a?!&&p=adc4eb77f8ae306e4f85a9677da390961c47ff631fed08eecc78862499a1ae77JmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly9tYXBzLmdvb2dsZS5jb20v&ntb=1
Google
https://www.bing.com/ck/a?!&&p=cce2c6c7cf92110082e6da28014cd8086c3ecaf0bd9b52dcb53bfdb80a051ad2JmltdHM9MTc2OTM4NTYwMA&ptn=3&ver=2&hsh=4&fclid=2c2623c0-af63-600b-1062-352dae3d619e&u=a1aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS9zb3JyeS9pbmRleA&ntb=1

Loading ...

Port Scanner (IP: 162.159.134.42)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 162.159.134.42)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with synthekine.com

Found 1 emails of this domain
1. [email protected]

Recent Searched Sites

› Zoodload.com (2 seconds ago) / IR

› Dpscale.com (2 seconds ago) / VN

› Synthekine.com (0 seconds ago) /

› Virtushealth.tfaforms.net (0 seconds ago) / AU

› Joball.tw (2 seconds ago) / TW

› Iwillreformyourhome.com (3 seconds ago) / BE

› Stadium.com.uy (2 seconds ago) / US

› Dubaioasistravel.ae (2 seconds ago) / US

› Ikupi.by (5 seconds ago) / BY

› Dragonballzhyper.fandom.com (1 seconds ago) / US

› Draftsol.com (0 seconds ago) / US

› Mtpro.dev (1 seconds ago) / US

› Romysmith.com (0 seconds ago) / NZ

› Grandbeach.hotels-miamibeach.com (1 seconds ago) / US

› Doubledsteakhouse.com (7 seconds ago) / US

› D25983ckyvjlyy.cloudfront.net (1 seconds ago) / US

› Spiderbeauty86.bravejournal.net (8 seconds ago) / US

› Frenchtestsimulator.com (2 seconds ago) / FR

› Hyper-liquid.at (5 seconds ago) / US

› Nexwayexports.com (1 seconds ago) / LT

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with synthekine.com on Search Engine

Synthekine | LinkedIn

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights …

Linkedin.com

Synthekine, Merck partner to develop new cytokine-based therapies

Synthekine and Merck have signed a global research collaboration and license agreement to develop novel cytokine-based therapeutics. As part of the collaboration, the companies will discover, develop, and market new cytokine-based therapies for the treatment of autoimmune diseases using Synthekine’s surrogate cytokine agonist platform.

Pharmaceutical-business-review.com

Synthekine Establishes Collaboration with Merck to Develop …

2021-11-01 · Synthekine will be eligible for up to $525 million in development, regulatory and commercialization milestones, as well as tiered royalties on …

Businesswire.com

Synthekine Establishes Collaboration with Merck to Develop …

2021-11-01 · MENLO PARK, Calif., November 01, 2021--Synthekine Inc., an engineered cytokine therapeutics company, today announced it has entered into a worldwide research collaboration and license agreement ...

Finance.yahoo.com

Synthekine Reviews | Glassdoor

Pros. - Team is very strong scientifically - Strong discovery platform - Very nice team mates, can always walk up to them with a question and receive help - Career development considered important at all levels - Open culture, anyone interested is involved in project teams (not sure if this can continue as the company gets bigger) - Great ...

Glassdoor.com

Synthekine - Funding, Financials, Valuation & Investors

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Crunchbase.com

Synthekine, Inc. Company Profile | Menlo Park, CA | Competitors ...

Company Description: Synthekine, Inc. is located in Menlo Park, CA, United States and is part of the Business, Professional, Labor, Political, and Similar Organizations Industry. Synthekine, Inc. has 22 total employees across all of its locations and generates $5.26 million in sales (USD). (Sales figure is modelled).

Dnb.com

Synthekine Management | Synthekine Management Team

The Synthekine management team includes Debanjan Ray (Chief Executive Officer), Martin Oft (Chief Development Officer), and Greg Yedinak (Senior Vice President, Technical Operations) . Get Contact Info for All Departments. David Mou.

Rocketreach.co

Synthekine, Inc. - Relationship Science

2021-06-01 · Harness the power of your relationships with RelSci, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward. This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Synthekine, Inc.. The use of any trade name or trademark is ...

Relationshipscience.com

LinkedIn Login, Sign in | LinkedIn

Linkedin.com

Synthekine Announces Multiple Poster Presentations Showcasing …

2022-04-07 · MENLO PARK, Calif., April 07, 2022--Synthekine Inc., an engineered cytokine therapeutics company, today announced five poster presentations based on research spanning each of its three distinct ...

Finance.yahoo.com

la solution contre les douleurs musculaires et courbatures - Atida

Syntholkiné, créateur de patchs chauffants innovants et de qualité. Syntholkiné propose des patchs chauffants pour soulager les douleurs musculaires, les crampes et les torticolis. Ces patchs, appliqués à même la peau, diffusent de la chaleur en continu grâce à leur composition en fer et en charbon activé qui produisent de la chaleur ...

Atida.fr

A forced marriage of IL-2 and PD-1 antibody nurtures tumor …

2022-02-01 · STK-012, a partial IL-2 agonist produced by Synthekine, employs a similar strategy by selectively binding IL-2Rα and IL-2Rβ subunits, but not IL-2Rγ. Effector T cells that may be specific for tumor epitopes can thus expand and readily attack the …

Ncbi.nlm.nih.gov

Synthekine, Inc | CipherBio

Explore Synthekine, Inc's investment information, scientific platforms, therapeutic approaches, indications and more here! Explore Synthekine, Inc's investment information, scientific platforms, therapeutic approaches, indications and more here! Home. PRO Data. Investor Insights. VC Funds Raised. M&A Insights. IPO Insights . Investors. Lead Investors. Accelerators & …

Cipherbio.com

Synthekine nabs megaround in bid to edge out Merck, Sanofi in IL …

2021-06-10 · Editor. Nine months after launching out of Stanford with $82 million and a portfolio of engineered cytokines, Synthekine has landed a $107.5 million Series B from Deer ...

Endpts.com

Synthekine email format | Synthekine.com emails

Synthekine uses 1 email formats: 1. (f)(lastname) ([email protected]). Enter a name to find and verify an email

Aeroleads.com

Synthekine Announces Publication of Preclinical Data ... - Benzinga

2021-12-23 · Synthekine designed its orthogonal IL-2 system to address these limitations of CD19 CAR-T cells and other adoptive cell therapies. Results from the preclinical studies show that treatment with STK ...

Benzinga.com

synthekine menlo park

HOME; ABOUT US. About Trust; Advisory Board; Anti Ragging Committee; Governing Body; CMD’S Message; THE INSTITUTE. Principal’s Message; …

Krishnaayurvedic.org

Michael Wong - Scientist I - Synthekine | LinkedIn

Nick Snead. “Michael and I have worked at Ambys, in different groups, for over two years. He is an incredibly talented and humble biotech professional who has experience contributing to high ...

Linkedin.com

Domains Expiration Date Updated

Site	Provider	Expiration Date
fnbct.com	101domain.com	-2 Years, -234 Days
drbacsi.com	godaddy.com	-3 Years, -235 Days
veggiehealth.net	cloudflare.com	-3 Years, -222 Days
obstri.com	godaddy.com	-2 Years, -20 Days
txxx.one	namesilo.com	-3 Years, -221 Days
swipo.media	godaddy.com	-3 Years, -356 Days
mysteerienmaailma.com	tucows.com	-3 Years, -359 Days
necrum.win	alibabacloud.com	-3 Years, -223 Days
pdxpharm.com	godaddy.com	324 Days
junxing-archery.com	cloudflare.com	-3 Years, -45 Days